While many of these changes were and are controversial, that procedure has a central role today in music theory, and is an essential part of the theory of sonata structure as taught in most music schools. Notable sonatas
Baroque (c. 1600 – c. 1760)
Johann Sebastian Bach
Sonatas for solo violin (BWV 1001, 1003 and 1005)
Sonatas for flute and continuo (BWV 1034, 1035)
Trio sonatas: for organ (BWV 525–530); for violin and harpsichord (BWV 1014–1019); for viola da gamba and harpsichord (BWV 1027–1029); for flute and harpsichord (BWV 1030, 1032); for flute, violin and continuo (Sonata sopril Soggetto Reale included in The Musical Offering)
Heinrich Ignaz Franz Biber
Rosary Sonatas
George Frideric Handel
Sonata for Violin and Continuo in D major (HWV 371)
Giuseppe Tartini
Devils Trill Sonata
Domenico Scarlatti
List of solo keyboard sonatas by Domenico Scarlatti

Classical (c. 1760 – c. 1830)
Wolfgang Amadeus Mozart
Piano Sonata No. 8 in A minor (K. 310)
Piano Sonata No. 11 in A major (K. 331/300i)
Piano Sonata No. 12 in F major (K. 332)
Piano Sonata No. 13 in B-flat major (K. 333)
Piano Sonata No. 14 in C minor (K. 457)
Piano Sonata No. 15 in F major (K. 533/494)
Piano Sonata No. 16 in C major (K. 545)
Sonata in A for Violin and Keyboard (K. 526)
Franz Joseph Haydn
Sonata No. 1 in C major, Hob. XVI:1 – Piano Sonata No. 62, Hob.XVI:52
Franz Schubert
Sonata in C minor, D. 958
Sonata in A major, D. 959
Sonata in B♭ major, D. 960

Romantic (c. 1795 – c. 1900)
Ludwig van Beethoven
Piano Sonata No. 8 "Pathétique"
Piano Sonata No. 14 "Moonlight" (Sonata quasi una fantasia)
Piano Sonata No. 17 "Tempest"
Piano Sonata No.
Contraindications
Calcipotriol/betamethasone dipropionate is contraindicated in patients with hypersensitivity to either glucocorticoids or vitamin D or disorders in calcium metabolism. This drug is also contraindicated for patients with erythrodermic, exfoliative, or pustular psoriasis. Adverse effects
A number of clinical studies have been conducted to investigate possible adverse events of this fixed combination corticosteroid and vitamin D analog. Safety and tolerability of calcipotriol/betamethasone dipropionate (Cal/BD) ointment has been assessed in a combined total of 2448 patients, exposed to treatment for 4 or 8 weeks (median weekly dose of 24.5 g). The most common adverse events for patients receiving Cal/BD were pruritus (3.1%), headache (2.8%), and nasopharyngitis (2.3%). Lesional/perilesional adverse events, defined as an adverse event located ≤2 cm from the lesional border, were reported by 8.7% of patients treated with Cal/BD ointment. Median time to onset of lesional/perilesional adverse events was 7 days.Adverse events during treatment with the foam formulation have been evaluated in three 4-week randomized, multicenter, prospective vehicle- and/or active-controlled clinical trials of subjects with plaque psoriasis. The median weekly dose was 24.8 g. Application site irritation, application site pruritus (itching), folliculitis (inflammation of hair follicles), skin hypopigmentation (loss of skin color), hypercalcemia (increased blood calcium levels), urticaria, and exacerbation of psoriasis were reported in <1% of subjects. Local long-term adverse effects of continuous steroid exposure may include skin atrophy, stretch marks, telangiectasia (spider veins), dryness, local infections, and miliaria ("prickly heat").